HepCBC is seeking individual patient input for our submission to the federal government for the first INTERFERON-FREE drug combo for GENOTYPE 4, AbbVie’s “2D-GT4”.
ADD YOUR VOICE! We will be accepting input from anyone affected by hepatitis C (ALL GENOTYPES, not only Genotype 4) between Friday, Sept. 11 and midnight on Thursday, Sept. 25, 2015 through this confidential online form:
PATIENT INPUT FORM for AbbVie 2D-GT4
Free WEBINAR about AbbVie 2D-GT4 available Monday, September 21st from 8 am – 9 am Pacific Time. Hosted by Canadian Treatment Action Council (CTAC).
EVER WONDER WHAT WE DO WITH YOUR INPUT? View all of our Patient Group Submissions since 2011 HERE!
FURTHER INFORMATION about this new treatment: the great links below about AbbVie 2D-GT4 put together by NATAP in the USA (Thanks, NATAP!):